Cargando…

Macrovascular complication phenotypes in type 2 diabetic patients

BACKGROUND: Macrovascular diseases (MVD) in type 2 diabetes mellitus (T2DM) are often considered all together, without discriminating the areas involved. The aim of our study was to analyse MVD prevalence in a large population of T2DM patients by dividing the cases into subgroups according to MVD si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papa, Giuseppe, Degano, Claudia, Iurato, Maria P, Licciardello, Carmelo, Maiorana, Raffaella, Finocchiaro, Concetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558439/ https://www.ncbi.nlm.nih.gov/pubmed/23331854 http://dx.doi.org/10.1186/1475-2840-12-20

Ejemplares similares

Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
por: Yoon, Hye-jin, et al.
Publicado: (2015)

The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates
por: Al-Maskari, Fatma, et al.
Publicado: (2007)

Genetics of macrovascular complications in type 2 diabetes
por: Tonyan, Ziravard N, et al.
Publicado: (2021)

Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus
por: Wang, Shenqi, et al.
Publicado: (2013)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study
por: Cardoso, Claudia R. L., et al.
Publicado: (2019)

Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study
por: Cardoso, Claudia R. L., et al.
Publicado: (2021)

Macrovascular Complications in Patients with Diabetes and Prediabetes
por: Huang, Dou, et al.
Publicado: (2017)

Proteasome modulator 9 and macrovascular pathology of T2D
por: Gragnoli, Claudia
Publicado: (2011)

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
por: Cardoso, C. R. L., et al.
Publicado: (2018)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
por: Kim, Jung Hee, et al.
Publicado: (2011)

Osteopontin for Early Detection of Microvascular and Macrovascular Type 1 Diabetic Complication
por: El Dayem, Soha M. Abd, et al.
Publicado: (2019)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
por: Rangel, Érika B., et al.
Publicado: (2019)

Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
por: Cardoso, Claudia R. L., et al.
Publicado: (2020)

Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy
por: van Ark, Joris, et al.
Publicado: (2013)

Evidence for congruent impairment in micro and macrovascular function in type 1 diabetes
por: Irace, Concetta, et al.
Publicado: (2017)

Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes
por: Cardoso, Claudia R. L., et al.
Publicado: (2016)

Low 25-hydroxyvitamin D(2) and 25-hydroxyvitamin D(3) levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study
por: Engelen, Lian, et al.
Publicado: (2015)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chawla, Aastha, et al.
Publicado: (2016)

Protective role of NRF2 in macrovascular complications of diabetes
por: Wu, Junduo, et al.
Publicado: (2020)

Cost of diabetes mellitus and related macrovascular complications in Turkiye
por: Birinci, Suayip, et al.
Publicado: (2023)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
por: Klen, Jasna, et al.
Publicado: (2015)

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria
por: Sibal, Latika, et al.
Publicado: (2009)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
por: D’Elia, John A, et al.
Publicado: (2010)

Role of Endoplasmic Reticulum Stress in Atherosclerosis and Diabetic Macrovascular Complications
por: Chistiakov, Dmitry A., et al.
Publicado: (2014)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: Tang, L., et al.
Publicado: (2017)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
por: Sun, Bao, et al.
Publicado: (2021)

Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications
por: Yang, Wei, et al.
Publicado: (2017)

Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia
por: Alaboud, Aboud F., et al.
Publicado: (2016)

Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
por: Hu, Yonghui, et al.
Publicado: (2021)

SUBCLINICAL HYPOTHYROIDISM AS A CONTRIBUTOR TO MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
por: Marushchak, Mariya, et al.
Publicado: (2021)

Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses
por: Mansour, Afnan, et al.
Publicado: (2023)

Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes
por: Sell, David R., et al.
Publicado: (2016)

Levels of soluble cell adhesion molecules in type 2 diabetes mellitus patients with macrovascular complications
por: Hegazy, Gehan A, et al.
Publicado: (2019)

Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
por: Wu, Zhiyuan, et al.
Publicado: (2022)

Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture
por: Bornfeldt, Karin E.
Publicado: (2015)

Macrovascular Complications and Prevalence of Urgency Incontinence in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study
por: Furukawa, Shinya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qn2fuqv08i5io135itafe9tv5e